Genetic Risk for Alzheimer Disease and Plasma Tau Are Associated With Accelerated Parietal Cortex Thickness Change in Middle-Aged Adults.
Jasmeet Pannu HayesMeghan E PierceEmma BrownDavid SalatMark W LogueJulie ConstantinescuKate E ValerioMark W MillerRichard ShervaBertrand Russell HuberWilliam MilbergRegina McGlincheyPublished in: Neurology. Genetics (2023)
Plasma tau, particularly when combined with genetic stratification for AD risk, can be a useful indicator of brain change in midlife. Accelerated inferior parietal cortex changes in midlife may be an important factor to consider as a marker of AD-related brain alterations.